<DOC>
	<DOCNO>NCT00845273</DOCNO>
	<brief_summary>The objective surveillance collect information 1 ) adverse drug reaction expect LPD ( unknown adverse drug reaction ) , 2 ) incidence adverse drug reaction surveillance , 3 ) factor consider affect safety and/or efficacy drug .</brief_summary>
	<brief_title>Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration</brief_title>
	<detailed_description>All patient investigator prescribes first Macugen® register consecutively number subject reach target number order extract patient enrol investigation random .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<criteria>Patients need administer Macugen® order enrol surveillance . Patients administer Macugen® .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Subfoveal choroidal neovascularization secondary age-related macular degeneration</keyword>
</DOC>